iCAD

Breast Health AI Solutions for breast cancer, including Detection, Density and Risk Assessment.

Company Overview

iCAD’s Artificial Intelligence Solutions for Breast Healthcare are built on deep learning technology and deliver powerful software solutions for digital breast tomosynthesis (DBT), 2D mammography, breast density and risk assessment. These innovative solutions offer clinicians a wide range of tools for breast cancer detection that also enhance workflow and improve overall efficiency. 

Headquartered in Nashua, NH, iCAD® is a global medical technology leader providing innovative cancer detection and therapy solutions. For over 30 years, iCAD has been delivering transformative innovations, aimed to precisely and effectively detect and treat cancer earlier, empowering clinicians to provide quality, cost-effective patient care.  

iCAD Inc. is renowned for its large multivendor compatibility, allowing seamless integration of their Breast Health Solutions into the diagnostic workflow. This commitment to interoperability enables healthcare providers to harness the power of AI in breast cancer detection without disrupting their existing imaging infrastructure, ultimately leading to improved patient care. 

iCAD-full-color-qf28012whis94c5jrv37qg1msf4zxgagizyzyrts2u

Modalities

modality MAM

Subspecialties

Wm Health icon

Applications available

iCAD-full-color-qf28012whis94c5jrv37qg1msf4zxgagizyzyrts2u

ProFound AI® for 2D Mammography & DBT

Detects malignant soft tissue densities and calcifications in 2D Mammography & Digital Breast Tomosynthesis.

CE

FDA

MAM

Breast

Oncology

Find out more >
iCAD-full-color-qf28012whis94c5jrv37qg1msf4zxgagizyzyrts2u

PowerLook® Density Assessment

Multi-vendor deep learning algorithm for standardizing breast density assessments.

FDA

CE

MAM

Breast

Oncology

Find out more >
iCAD-full-color-qf28012whis94c5jrv37qg1msf4zxgagizyzyrts2u

ProFound AI® Risk

Clinical decision support tool that provides accurate and tailored short-term breast cancer risk estimation.

CE

FDA

MAM

Breast

Oncology

Find out more >

To find out more about iCAD’s solutions, or the 100+ other applications on the Blackford Platform, book a discovery call with our team.

review image 1

Book a meeting

We’d welcome the opportunity to learn more about your AI needs and to explain how partnering with Blackford can drive efficiency and provide ongoing value.

Book a Meeting